Osaic Holdings’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-2,615
| Closed | -$105K | – | 8004 |
|
|
2026
Q1 | $105K | Sell |
2,615
-115
| -4% | -$2.48K | ﹤0.01% | 4647 |
|
|
2025
Q4 | $68.6K | Sell |
2,730
-424
| -13% | -$9.95K | ﹤0.01% | 5014 |
|
|
2025
Q3 | $80K | Buy |
3,154
+472
| +18% | +$11K | ﹤0.01% | 4965 |
|
|
2025
Q2 | $46.6K | Buy |
2,682
+1,570
| +141% | +$29.1K | ﹤0.01% | 5099 |
|
|
2025
Q1 | $24.3K | Sell |
1,112
-233
| -17% | -$6.44K | ﹤0.01% | 5219 |
|
|
2024
Q4 | $36.8K | Sell |
1,345
-769
| -36% | -$23.1K | ﹤0.01% | 4919 |
|
|
2024
Q3 | $61K | Sell |
2,114
-158
| -7% | -$5.85K | ﹤0.01% | 4601 |
|
|
2024
Q2 | $87.2K | Sell |
2,272
-729
| -24% | -$33K | ﹤0.01% | 4252 |
|
|
2024
Q1 | $176K | Sell |
3,001
-2,990
| -50% | -$191K | ﹤0.01% | 3792 |
|
|
2023
Q4 | $359K | Sell |
5,991
-60
| -1% | -$3.04K | ﹤0.01% | 3438 |
|
|
2023
Q3 | $230K | Buy |
6,051
+1,082
| +22% | +$47.5K | ﹤0.01% | 3891 |
|
|
2023
Q2 | $452K | Sell |
4,969
-9,268
| -65% | -$800K | ﹤0.01% | 3233 |
|
|
2023
Q1 | $939K | Buy |
14,237
+10,988
| +338% | +$634K | ﹤0.01% | 2531 |
|
|
2022
Q4 | $167K | Buy |
3,249
+209
| +7% | +$11.1K | ﹤0.01% | 4015 |
|
|
2022
Q3 | $209K | Buy |
3,040
+373
| +14% | +$22.1K | ﹤0.01% | 3693 |
|
|
2022
Q2 | $120K | Buy |
2,667
+62
| +2% | +$2.83K | ﹤0.01% | 4261 |
|
|
2022
Q1 | $132K | Sell |
2,605
-741
| -22% | -$32.7K | ﹤0.01% | 4361 |
|
|
2021
Q4 | $158K | Sell |
3,346
-655
| -16% | -$25.8K | ﹤0.01% | 4171 |
|
|
2021
Q3 | $132K | Buy |
4,001
+1,788
| +81% | +$100K | ﹤0.01% | 4280 |
|
|
2021
Q2 | $139K | Buy |
2,213
+7
| +0.3% | +$361 | ﹤0.01% | 4197 |
|
|
2021
Q1 | $95K | Sell |
2,206
-90
| -4% | -$4.26K | ﹤0.01% | 4390 |
|
|
2020
Q4 | $131K | Sell |
2,296
-100
| -4% | -$4.23K | ﹤0.01% | 3842 |
|
|
2020
Q3 | $73K | Hold |
2,396
| – | – | ﹤0.01% | 4044 |
|
|
2020
Q2 | $78K | Sell |
2,396
-160
| -6% | -$5.14K | ﹤0.01% | 3868 |
|
|
2020
Q1 | $68K | Buy |
+2,556
| New | +$90.7K | ﹤0.01% | 3750 |
|
Other funds holding APLS
Osaic Holdings's APLS Position: Q2 2026 in Review
Osaic Holdings sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 2,615 shares — an estimated $105K sold.
Osaic Holdings first reported a position in APLS in Q1 2020 and held it in 25 quarters. The position peaked at $939K in Q1 2023. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.
- Osaic Holdings reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
- Osaic Holdings sold 2,615 Apellis Pharmaceuticals shares in Q2 2026, an estimated $105K.
- Osaic Holdings first reported a position in Apellis Pharmaceuticals in Q1 2020 and held it in 25 quarters.
- Osaic Holdings's Apellis Pharmaceuticals position peaked at $939K in Q1 2023.
- 1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.
Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.